Eleusis Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression (NCT05434156) | Eleusis Therapeutics | 2022-10-27 |
| A Dose-Ranging Study of 50 µg to 100 µg LSD in Healthy Volunteers (NCT05674669) | Eleusis Therapeutics | 2015-10-20 |
| A Double-blind, Placebo-controlled Study to Evaluate Very Low Dose LSD in Healthy Volunteers Aged 55-75 Years (NCT04421105) | Eleusis Therapeutics | 2015-06-29 |
Track Eleusis Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.